Metabolism

Liver Fibrosis Models

Biocytogen has developed CCL4-induced, TAA-induced, and bile duct ligation-induced liver fibrosis mouse models for drug evaluation.

on this page

  • Liver Fibrosis Model Introduction
  • Results

Publication

    Liver Fibrosis Model Introduction

    Liver fibrosis is a common consequence of liver injury caused by various chronic liver diseases and can progress to advanced conditions such as cirrhosis and hepatocellular carcinoma. Targeting key molecular pathways involved in fibrosis, such as TGF-β and PDGF, has become a promising approach for therapeutic intervention. Research into these targets aims to halt or reverse fibrosis progression, offering hope for the treatment of liver-related diseases.

    Biocytogen has developed CCL4-induced, TAA-induced, and bile duct ligation-induced liver fibrosis mouse models for drug evaluation.

    Results
    CCL4 Induced Liver Fibrosis Mouse Model

    Carbon tetrachloride (CCl4)-induced hepatic fibrosis and cirrhosis in rodents is a well-established and widely accepted experimental model for the study of liver fibrosis and cirrhosis. In many aspects it mirrors the pattern of human disease associated with toxic damage. For example, the α-SMA expression, Stellate cell activation and key matrix components including collagen-1, MMPs and their inhibitors.

    Establishment of CCL4-induced liver fibrosis model

    Liver weight, body weight, ALT and AST levels in serum were detected after CCl4 induction. Values are expressed as mean ± SEM. N = 6 mice per group. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001.

    H&E staining showing inflammation infiltration and Sirius red staining showing fibrosis in liver. Values are expressed as mean ± SEM. N = 6 mice per group. **p<0.01, ***p<0.001.

    Immunohistochemistry showing fibroblast marker α-SMA in liver. Values are expressed as mean ± SEM. N = 6 mice per group .***p<0.001, ****p<0.0001.

    Efficacy Validation on liver fibrosis Mouse Models for OCA (Obeticholic Acid)

    A. Representative pictures of Sirius red staining showing liver fibrosis after 3 weeks of CCl4 induction and OCA treatment. B. Statistic data of Sirius red staining. Values are expressed as mean ± SEM. N = 6 mice per group.*p<0.05.